Pinnacle Associates’s Dr. Reddy's Laboratories RDY Stock Holding History

Pinnacle Associates’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-56,820	Closed	-$726K	–	668
2015 Q3	$726K	Sell	56,820 -420	-0.7%	-$5.22K	0.02%	405
2015 Q2	$633K	Buy	57,240 +1,525	+3%	+$16.8K	0.01%	439
2015 Q1	$636K	Sell	55,715 -2,250	-4%	-$23.9K	0.01%	441
2014 Q4	$585K	Hold	57,965	–	–	0.01%	436
2014 Q3	$609K	Sell	57,965 -16,010	-22%	-$151K	0.01%	433
2014 Q2	$638K	Buy	73,975 +400	+0.5%	+$3.36K	0.01%	429
2014 Q1	$646K	Buy	73,575 +2,250	+3%	+$19.6K	0.01%	418
2013 Q4	$585K	Sell	71,325 -400	-0.6%	-$3.17K	0.01%	435
2013 Q3	$542K	Sell	71,725 -25,090	-26%	-$182K	0.01%	430
2013 Q2	$732K	Buy	+96,815	New	+$707K	0.02%	374

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Pinnacle Associates's RDY Position: Q4 2015 in Review

Pinnacle Associates sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 56,820 shares — an estimated $726K sold.

Pinnacle Associates first reported a position in RDY in Q2 2013 and held it in 10 quarters. The position peaked at $732K in Q2 2013. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

Pinnacle Associates reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
Pinnacle Associates sold 56,820 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $726K.
Pinnacle Associates first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 10 quarters.
Pinnacle Associates's Dr. Reddy's Laboratories position peaked at $732K in Q2 2013.
174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Pinnacle Associates's 13F filing for Q4 2015, filed 9 Feb 2016.